Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 90 | ECE2023 | Next issue

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

Card image cap
ECE 2023 will be held in Istanbul, Turkey from 13-16 May 2023. Istanbul is known for its rich culture, historical sites and dynamic nightlife, and we are excited to come together in this city, and look forward to meeting old friends, making new ones, and sharing science, collaborations and ideas.

Oral Communications

Oral Communications 2: Thyroid

ea0090oc2.1 | Oral Communications 2: Thyroid | ECE2023

Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy: The levolio study

Brigante Giulia , Santi Daniele , Boselli Gisella , Margiotta Gianluca , Corleto Rossella , Monzani Maria Laura , Craparo Andrea , Locaso Michela , Sperduti Samantha , Roy Neena , Casarini Livio , Trenti Tommaso , Varani Manuela , De Santis Maria Cristina , Roli Laura , Rochira Vincenzo , Simoni Manuela

Introduction: Despite normal thyroid-stimulating hormone serum levels, up to 60% of hypothyroid patients are dissatisfied with the treatment. Animal studies suggest that the persistence of symptoms may derive from peripheral hypothyroidism. Combination treatment with levothyroxine and liothyronine is a theoretically plausible solution but its efficacy is still questionable.Aim: To evaluate the effects of personalized twice-daily combination therapy on pe...

ea0090oc2.2 | Oral Communications 2: Thyroid | ECE2023

Faecal microbiota signature in hypothyroid patients with refractoriness to levothyroxine treatment

Virili Camilla , Capriello Silvia , Stramazzo Ilaria , Filardo Simone , Pietro Marisa Di , Sessa Rosa , Centanni Marco

Despite an accurate management, in about 20% of hypothyroid patients showing an increased need for oral levothyroxine (LT4), the leading cause of treatment refractoriness remains unknown. Some studies hypothesized the relationship between gut microbiota composition and thyroid homeostasis, but the possible involvement of microflora in the efficacy of LT4 treatment has not been evaluated yet, and this represents the aim of our study. We examined the faecal microflora compositio...

ea0090oc2.3 | Oral Communications 2: Thyroid | ECE2023

The variable clinical spectrum of Thyroid Hormone Resistance Syndrome type β: two different presentations of the same disease

Martins Ferreira Mafalda , Lopes Sofia , Araujo Catia , Oliveira Patricia , Moreno Carolina , Paiva Isabel

Thyroid hormone resistance syndrome(THRS) occurs in 1:40000 live births and can be diagnosed after a period of enigmatic changes in thyroid hormones(TH). Patients may be clinically euthyroid, have clinical hypo or hyperthyroidism. Mostly, it is an autosomal dominant disease due to germline mutations in THRβ-gene(exons 7-10). Resistance to peripheral action of TH leads to absence of TSH suppression (which can be normal/elevated) despite elevated fT4 and fT3.<p class="a...

ea0090oc2.4 | Oral Communications 2: Thyroid | ECE2023

TSH suppression increases the risk of sarcopenia and frailty in the long-term follow-up of elderly patients with differentiated thyroid carcinoma

Coskun Meric , Cataltepe Esra , Varan Hacer Dogan , Ceker Eda , Bektas Yasemin , Kuscu Yasemin , Yalcin Mehmet Muhittin , Akturk Mujde , Toruner Fusun Balos , Karakoc Mehmet Ayhan , Altinova Alev Eroglu

Objective: In differentiated thyroid carcinoma (DTC), TSH suppression with levothyroxine (L-T4) is a standard treatment for reducing tumor recurrence after total thyroidectomy. This study aims to evaluate the effect of long-term TSH suppression on the development of sarcopenia and frailty in elderly patients with DTC.Method: Seventy patients aged 60 years and older with stable TSH levels during the last year and under L-T4 due to DTC were included in the...

ea0090oc2.5 | Oral Communications 2: Thyroid | ECE2023

Circulating Long Non-Coding RNAs as a non-invasive markers to help differentiate benign from malignancy in indeterminate thyroid nodules

Dutta Susmita , Tarafdar Soham , Bhattacharyya Nitai P. , Mukhopadhyay Pradip , Ghosh Sujoy

Introduction: Molecular testing is being increasingly used to detect malignancy in indeterminate thyroid nodules (Bethesda 3 & 4) which pose diagnostic dilemma. Long non-coding RNAs are crucial for metastasis, angiogenesis, and tumour growth of various cancers. Clinical utility of plasma lncRNAs as non-invasive diagnostic markers for thyroid cancer especially in indeterminate nodule remains unexplored.Methodology: We selected lncRNAs relevant to thyr...

ea0090oc2.6 | Oral Communications 2: Thyroid | ECE2023

CD3+CD8+CD20+T lymphocytes behave differently in autoimmune thyroiditis and related polyautoimmune disorders: A pilot study

Stramazzo Ilaria , Mangino Giorgio , Fallahi Poupak , Santaguida Maria Giulia , Gargano Lucilla , Capriello Silvia , Virili Camilla , Centanni Marco

The presence and the role of CD20+ T cells in humans has been described in autoimmune disorders such as multiple sclerosis and rheumatoid arthritis. In healthy subjects, CD3+CD20+ T cells are detected in all lymphatic organs and in the cerebrospinal fluid and represent about 5% of circulating T cells. Some reports described their production of high levels of IL-17A and/or IFN-γ. This study was aimed at investigating the behavior of CD3<sup...